Please assess the completion status of the following clinical trial:

Trial Title: Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Between 20 and 85 years old~* Liver cirrhosis associated with esophageal varices or gastric varices~* Gastric ulcer or duodenal ulcer ,size bigger or egual than 0.5 cm~Exclusion Criteria:~* Acute bleeding~* Steroid or NSAID user~* Pregnancy, or the patients with other terminal illness (such as other terminal cancers, heart failure, renal failure...)~* Propranolol contraindications (such as atrioventricular block, heart failure, chronic obstructive pulmonary disease, asthma, poorly controlled diabetes, severe peripheral arterial disease...)

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Proton-pump inhibitor (Type: PLACEBO_COMPARATOR): PPI: Pariet EC 20 mg/QDAC
- Propranolol+Proton-pump inhibitor (Type: ACTIVE_COMPARATOR): Propranolol:~Propranolol 10mg BID initially and titrate dosage every week to achieve 25% drop of heart rate (keep heart rate\>55 or systemic blood pressure\>90mmHg)~PPI: Pariet EC 20 mg/QDAC

Based on this trial design, predict the completion outcome and termination type (if applicable).